Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/1994
11/30/1994EP0626177A2 Nutrition for persons infected with human immunodeficiency virus
11/30/1994EP0626168A1 Novel rafting antacid composition
11/30/1994EP0625989A1 Dna sequences encoding novel growth/differentiation factors
11/30/1994EP0531410B1 (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(fluorophenyl)ethyl]-4-piperidinemethanol
11/30/1994CN1095593A Agent for preventing and treating disturbances of intestinal mucous membrane
11/26/1994CA2122886A1 Saccharin derivative proteolytic enzyme inhibitors
11/25/1994CA2123534A1 Rafting antacid formulation
11/24/1994WO1994026915A1 Gene transfer into pancreatic and biliary epithelial cells
11/24/1994WO1994026891A2 Purified mammalian flt3 ligands and agonists and antagonists thereof
11/24/1994WO1994026740A1 Heteroatom substituted alkyl benzylaminoquinuclidines as substance p antagonists
11/24/1994WO1994026735A1 Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
11/24/1994WO1994026719A1 Mercapto-amide derivatives useful as neutral endopeptidase and ace inhibitors
11/24/1994WO1994026306A1 Conserved motif of hepatitis c virus e2/ns1 region
11/24/1994WO1994026288A1 Psyllium drink mix compositions
11/24/1994WO1994026269A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
11/24/1994WO1994026268A1 Methods and compositions using optically pure (+)-zileuton
11/24/1994WO1994026249A1 Compositions and methods for reparation and prevention of fibrotic lesions
11/24/1994WO1994022413A3 Triazole substituted quinoline derivatives
11/24/1994CA2162602A1 Gene transfer into pancreatic and biliary epithelial cells
11/24/1994CA2161978A1 Methods and compositions for treating asthma, atherosclerosis and inflammatory diseases using optically pure (-)-zileuton
11/24/1994CA2161777A1 Methods and compositions using optically pure (+)-zileuton
11/24/1994CA2161648A1 Compositions and methods for reparation and prevention of fibrotic lesions
11/23/1994EP0625204A1 Hepatitis therapeutics
11/23/1994EP0625151A1 Thiazolyl-pyridine derivatives and their use as gastric acid secretion inhibitors
11/23/1994EP0625145A1 3-phenylureido-azepin-2-ones and -benzazepin-2-ones useful as cholecystokinin antagonists
11/23/1994EP0625144A1 Pyridone derivatives, their preparation and use as medicines
11/23/1994EP0625143A1 Pyridine derivatives, their preparation and use as medicines
11/23/1994EP0625138A1 Novel amidine derivatives, their preparation and their use as mediaments with ltb-4 antagonistic effect
11/23/1994CN1095417A Improvements in or relating to organic compounds
11/23/1994CN1095268A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/23/1994CN1095262A Oral compositions containing antiplaque, anticalculus agents
11/22/1994US5367056 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/22/1994US5366735 Method and composition for post-surgical adhesion reduction
11/22/1994CA1333156C Dispersible cimetidine tablets
11/17/1994EP0624588A1 New quinoline derivatives with pharmacological activity
11/17/1994EP0624164A1 Peptides with organo-protective activity, process for their preparation and their use in the therapy
11/17/1994EP0624159A1 Pyridyl substituted imidazoles
11/16/1994CN1095062A Preparation of pure enantiomorisomer
11/16/1994CN1026586C Novel thiazolidinone derivatives, pharmaceutical compositions containing them and process for preparing same
11/15/1994US5364943 Preparation of substituted piperidines
11/15/1994US5364868 Amino-substituted benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them
11/15/1994US5364856 Modification of serotonin function
11/15/1994US5364853 Treatment of disorders associated with vascular, respiratory, gastrointestinal tract, urinary bladder or uterus smooth muscle contraction
11/15/1994US5364652 Potato starch treated with heat and hydrochloric acid and hydrolyzed with amylase and glucoamylase; dietetics; fibers; foods
11/15/1994US5364636 Inhibitor of absorption of digestion product of food and drink
11/10/1994WO1994025601A2 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
11/10/1994WO1994025445A1 1,5-benzodiazepines useful as gastrin or cck-antagonists
11/10/1994WO1994025444A1 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or cck antagonists
11/10/1994WO1994025435A1 Peptidyl derivatives and their use as metalloproteinase inhibitors
11/10/1994WO1994025431A1 Cyclooxygenase and 5-lipoxygenase inhibiting n(3-biphenylyl-1(s)-methyl-2-propenyl) acetohydroxamic acid derivatives
11/10/1994WO1994025430A1 Cyclooxygenase and 5-lipoxygenase inhibiting hydroxamic acid derivatives
11/10/1994WO1994025427A1 Ethanolamine derivatives useful for the treatment of gastrointestinal disorders
11/10/1994WO1994025070A1 Veterinary composition containing a proton pump inhibitor
11/10/1994WO1994025060A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
11/10/1994WO1994025049A1 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
11/10/1994WO1994025043A1 Peptides and compounds that bind to elam-1
11/10/1994WO1994025028A1 Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
11/10/1994WO1994025002A1 Lactulose lozenges
11/10/1994WO1994024867A1 Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
11/10/1994CA2662090A1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
11/10/1994CA2161544A1 Cyclooxygenase and 5-lipoxygenase inhibiting n(3-biphenylyl- 1(s)-methyl-2-propenyl) acetohydroxamic acid derivatives
11/10/1994CA2161216A1 Amidino and guanidino substituted boronic acid inhibitors of tryspin-like enzymes
11/10/1994CA2161130A1 Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
11/10/1994CA2139129A1 Peptidyl derivatives and their use as metalloproteinase inhibitors
11/09/1994EP0623623A1 2-aminoethanesulfonic acid/zinc complex
11/09/1994EP0623620A1 5-HT3 Pyrrolopyrazine derivatives
11/09/1994EP0623592A1 Peptide analogs as irreversible interleukin-1beta protease inhibitors
11/09/1994EP0623143A1 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
11/09/1994EP0623133A1 Substituted amino alkyl compounds
11/09/1994EP0623118A1 Carbamate derivatives and their use in medicine
11/09/1994EP0623116A1 Amino acid derivatives as paf-receptor antagonists
11/09/1994EP0623114A1 Phenyl-imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists
11/09/1994EP0623021A1 4''-deoxyerythromycin derivatives
11/09/1994CN1094724A 6-heterocyclic-4-amino1,3,4,5-tetrahydrobenzÛCDÙindoles for treating motion sickness and vomiting
11/09/1994CN1094642A Therapeutic combination
11/09/1994CN1094628A Antidiarrheal Chinese medicine
11/08/1994US5362740 Dihydrobenzofuran carboxamides and process for their preparation
11/08/1994US5362734 Certain benzo-quinolizine compounds and derivatives thereof
11/08/1994US5362480 Microbiocides
11/08/1994CA2123057A1 Quinoline derivatives with pharmacological activity
11/02/1994EP0621788A1 Hemoregulatory peptides
11/02/1994EP0621782A1 Agent for preventing and treating disturbances of intestinal mucous membrane
11/02/1994EP0561863B1 Amidic derivatives of glutamic, aspartic and 2-amino adipic acids with antigastrin activity
11/02/1994EP0396560B1 Process for increasing the growth rate and/or utilization of fodder or foodstuffs and/or resistance in animals and humans
11/02/1994CN1094446A ECK receptor ligands
11/01/1994US5360820 Medical use for tachykinin antagonists
11/01/1994US5360793 Foaming, xanthan gum, hexitol-stabilized aluminum hydroxide
11/01/1994CA1332839C 8-substituted quinoline derivatives and their use in therapy
10/1994
10/31/1994CA2122290A1 Pyrrolopyrazinic compounds, methods for their preparation and pharmaceutical compositions containing them
10/30/1994CA2122227A1 Peptide analogs as irreversible interleukin-1.beta. protease inhibitors
10/27/1994WO1994024151A1 1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity
10/27/1994WO1994024130A1 New pyridinium salts and their use for controlling helicobacter bacteria
10/27/1994WO1994024127A1 Indole derivatives as 5-h1-like agonists for use in migraine
10/27/1994WO1994023720A1 Tetrahydro-beta-carbolines
10/27/1994CA2160481A1 Tetrahydro-beta-carbolines
10/27/1994CA2158972A1 1,5-benzodiazepine derivatives having cck and/or gastrin antogonistic activity
10/26/1994EP0621271A1 Benzoxazole derivatives and their use as serotonin 5-HT3 receptor antagonists
10/26/1994CN1094092A Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides
10/26/1994CN1094052A Heterocycle-containing carbonic acid derivatives
10/26/1994CN1094049A Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents